发明授权
- 专利标题： Chemokine receptor antagonists and methods of use therefor
- 专利标题（中）： 趋化因子受体拮抗剂及其使用方法
-
申请号： US12436271申请日： 2009-05-06
-
公开(公告)号： US08058287B2公开(公告)日： 2011-11-15
- 发明人: Jay R. Luly , Yoshisuke Nakasato , Etsuo Ohshima , Geraldine C. B. Harriman , Kenneth G. Carson , Shomir Ghosh , Amy M. Elder , Karen M. Mattia
- 申请人： Jay R. Luly , Yoshisuke Nakasato , Etsuo Ohshima , Geraldine C. B. Harriman , Kenneth G. Carson , Shomir Ghosh , Amy M. Elder , Karen M. Mattia
- 申请人地址： US MA Cambridge JP Tokyo
- 专利权人： Millennium Pharmaceuticals, Inc.,Kyowa Hakko Kirin Co., Ltd.
- 当前专利权人： Millennium Pharmaceuticals, Inc.,Kyowa Hakko Kirin Co., Ltd.
- 当前专利权人地址： US MA Cambridge JP Tokyo
- 代理机构： McDermott Will & Emery LLP
- 主分类号： C07D491/00
- IPC分类号： C07D491/00 ; C07D498/00 ; C07D515/00 ; A01N43/42 ; A61K31/44
摘要：
Disclosed are novel compounds and a method of treating a disease associated with aberrant leukocyte recruitment and/or activation. The method comprises administering to a subject in need an effective amount of a compound represented by: or physiologically acceptable salt thereof.
公开/授权文献
信息查询
